Regulation 37 Amendment of Schedule 8
Schedule 8 (material to accompany an application for a UK marketing authorisation)f1 is amended as follows.
In paragraph 9A, at the beginning insert “Except in the case of an active substance that contains human cells or tissues, or that is part of a medicinal product which is (or is in a form which means a dose or part of it is) to be administered immediately after manufacture,”.
For paragraph 16 substitute the following—
“16.(1)Subject to sub-paragraph (2), a mock-up, in accordance with Part 13 (packaging and leaflets) of—
(a)the outer packaging of the medicinal product;
(b)the immediate packaging of the medicinal product; and
(c)the package leaflet for the medicinal product.
(2)Sub-paragraph (1)(a) and (b) does not apply to an application for a marketing authorisation for a POC medicinal product which is (or is in a form which means a dose or part of it is) to be administered immediately after manufacture.”.
Annotations
Footnotes
- f1
-
Paragraph 9A was inserted by S.I. 2013/1855. There are other amendments but none is relevant.